Notably, in HER2-positive breast cancer, the presence of TLSs significantly correlates with better DFS, independently of high TIL expression, indicating that the combined status of TLSs and TILs represents an independent favorable factor related to DFS.422. Here, ERBB2 is linked to breast cancer.